PharmaEssentia USA News and Activities

PharmaEssentia USA is owned by PharmaEssentia.

PharmaEssentia is a company listed under the stock ticker 6446 (TW).

PharmaEssentia has a direct presence in 3 countries.

PharmaEssentia has 3 subsidiaries including PharmaEssentia Innovation Research Center, PharmaEssentia Japan and PharmaEssentia USA.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 20 main executives

Most searched biographies at PharmaEssentia USA

• Ko-Chung Lin, Chief Executive Officer and US General Manager
• Jeffrey Williams, Independent Director
• Barry Flannelly, Independent Director

Popular executive movements at PharmaEssentia USA

• Eric Vogel has joined the company as Head of Commercialization  (posted on May 27 2026).
• Jeffrey Williams has joined the company as Independent Director  (posted on December 25 2025).
• Barry Flannelly has joined the company as Independent Director  (posted on November 11 2025).

Create your alert
to follow the executive moves at PharmaEssentia USA.

PharmaEssentia has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by PharmaEssentia USA

Social media about PharmaEssentia USA

• PharmaEssentia USA on Wikipedia, Google News & Yahoo Finance
• PharmaEssentia USA on LinkedIn, X (Twitter) & YouTube